2-Year Outcomes of Angiographic Quantitative Flow Ratio-Guided Coronary Interventions.
Lei Song,Bo Xu,Shengxian Tu,Changdong Guan,Zening Jin,Bo Yu,Guosheng Fu,Yujie Zhou,Jian'an Wang,Yundai Chen,Jun Pu,Lianglong Chen,Xinkai Qu,Junqing Yang,Xuebo Liu,Lijun Guo,Chengxing Shen,Yaojun Zhang,Qi Zhang,Hongwei Pan,Rui Zhang,Jian Liu,Yanyan Zhao,Yang Wang,Kefei Dou,Ajay J. Kirtane,Yongjian Wu,William Wijns,Weixian Yang,Martin B. Leon,Shubin Qiao,Gregg W. Stone
DOI: https://doi.org/10.1016/j.jacc.2022.09.007
IF: 24
2022-01-01
Journal of the American College of Cardiology
Abstract:BACKGROUND In the multicenter, randomized, sham-controlled FAVOR (Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease) III China trial, quantitative flow ratio (QFR)-based lesion selection improved 1-year clinical outcomes compared with conventional angiographic guidance for percutaneous coronary intervention (PCI).OBJECTIVES The purpose of this study was to determine whether the benefits of QFR guidance persist at 2 years, particularly for patients in whom QFR changed the revascularization strategy. METHODS Eligible patients were randomized to a QFR-guided strategy (PCI performed only if QFR #0.80) or a stan-dard angiography-guided strategy. Major adverse cardiac events (MACE), a composite of all-cause death, myocardial infarction (MI), or ischemia-driven revascularization occurring within 2 years were analyzed in the intention-to-treat population.RESULTS Among 3,825 randomized participants, 2-year MACE occurred in 161 of 1,913 (8.5%) patients in the QFR-guided group and in 237 of 1,912 (12.5%) patients in the angiography-guided group (HR: 0.66; 95% CI: 0.54-0.81; P < 0.0001), driven by fewer MIs (4.0% vs 6.8%; HR: 0.58; 95% CI: 0.44-0.77; P = 0.0002) and ischemia-driven revascularizations (4.2% vs 5.8%; HR: 0.71; 95% CI: 0.53-0.95; P = 0.02) in the QFR-guided group. Landmark analysis showed consistent results within the first year and between 1-2 years (Pint = 0.99). Although the 2-year MACE rate was lower in the QFR-guided group in both patients with and without revascularization strategy changes, the extent of outcome improvement was greater (Pint = 0.009) among those patients in whom the preplanned PCI strategy was modified by QFR.CONCLUSIONS QFR-guided lesion selection improved 2-year clinical outcomes compared with standard angiography guidance. The benefits were most pronounced among patients in whom QFR assessment altered the planned revascu-larization strategy. (FAVOR III China Study [The Comparison of Quantitative Flow Ratio Guided and Angiography Guided Percutaneous Intervention in Patients with Coronary Artery Disease] NCT03656848) (J Am Coll Cardiol 2022;80:2089-2101) (c) 2022 by the American College of Cardiology Foundation.